ResearcherFujian Medical UniversityActive in the last 2 years

Ling Wang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5128640424. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2026: 2 papers

Papers 2

Prostaglandin E2-driven dedifferentiation of Schwann cells leads to perineural invasion in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41392-026-02648-x ↗
PIEZO1 enhances pancreatic cancer neurotropism. Co-author DOI 10.1186/s12935-026-04244-z ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Feng Gao · 2 shared papers, 2026 · strength 0.59
- Paper PIEZO1 enhances pancreatic cancer neurotropism. DOI 10.1186/s12935-026-04244-z ↗
- Paper Prostaglandin E2-driven dedifferentiation of Schwann cells leads to perineural invasion in pancreatic ductal adenocarci… DOI 10.1038/s41392-026-02648-x ↗
Shangeng Weng · 2 shared papers, 2026 · strength 0.59
- Paper PIEZO1 enhances pancreatic cancer neurotropism. DOI 10.1186/s12935-026-04244-z ↗
- Paper Prostaglandin E2-driven dedifferentiation of Schwann cells leads to perineural invasion in pancreatic ductal adenocarci… DOI 10.1038/s41392-026-02648-x ↗
Qicai Liu · 2 shared papers, 2026 · strength 0.59
- Paper PIEZO1 enhances pancreatic cancer neurotropism. DOI 10.1186/s12935-026-04244-z ↗
- Paper Prostaglandin E2-driven dedifferentiation of Schwann cells leads to perineural invasion in pancreatic ductal adenocarci… DOI 10.1038/s41392-026-02648-x ↗
Jinhong Li · 1 shared paper, 2026 · strength 0.32
- Paper PIEZO1 enhances pancreatic cancer neurotropism. DOI 10.1186/s12935-026-04244-z ↗
Jiahong Dong · 1 shared paper, 2026 · strength 0.27
- Paper Prostaglandin E2-driven dedifferentiation of Schwann cells leads to perineural invasion in pancreatic ductal adenocarci… DOI 10.1038/s41392-026-02648-x ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.